bromocriptine has been researched along with Hallucinations in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, SY; Ratnagopal, P; Tan, EK; Wong, MC | 1 |
| Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F | 1 |
| Harris, PL | 1 |
| Goodkin, DA | 1 |
| Lauterbach, EC | 1 |
| Comella, CL; Ristanovic, RK; Tanner, CM | 1 |
| Graham, JM; Grünewald, RA; Sagar, HJ | 1 |
| Burke, DT; Calvanio, R; Fitzpatrick, M; Karli, DC; Kim, HJ; Lepak, P; Macneil, M; Pesez, K; Temple, D | 1 |
| Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F | 1 |
| Angrist, B; Lieberman, A; Serby, M | 1 |
| Parkes, D | 1 |
| Lance, JW; Mackenzie, RA | 1 |
| Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E | 1 |
| Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Dichgans, J; Scholz, E | 1 |
| Sandyk, R | 1 |
| Montastruc, JL; Rascol, A; Schmitt, L; Simonetta, M | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
2 review(s) available for bromocriptine and Hallucinations
| Article | Year |
|---|---|
Bromocriptine.
Topics: Acromegaly; Animals; Behavior, Animal; Biogenic Amines; Bromocriptine; Central Nervous System; Dopamine; Emetics; Female; Galactorrhea; Growth Hormone; Hallucinations; Hemodynamics; Hormones; Humans; Kinetics; Norepinephrine; Parkinson Disease; Pregnancy; Prolactin; Receptors, Dopamine; Serotonin | 1977 |
[Psychiatric manifestations induced by dopamine precursors or antagonists].
Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride | 1979 |
3 trial(s) available for bromocriptine and Hallucinations
| Article | Year |
|---|---|
Piribedil and bromocriptine in Parkinson's disease: a single-blind crossover study.
Topics: Administration, Oral; Aged; Antiparkinson Agents; Bromocriptine; Cross-Over Studies; Female; Hallucinations; Humans; Male; Middle Aged; Nausea; Parkinson Disease; Piribedil; Psychomotor Agitation; Severity of Illness Index; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome | 2003 |
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease | 2002 |
An evaluation of bromocriptine in the treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease | 1978 |
13 other study(ies) available for bromocriptine and Hallucinations
| Article | Year |
|---|---|
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception | 2004 |
Bromocriptine and hallucinations.
Topics: Bromocriptine; Female; Hallucinations; Humans | 1984 |
Mechanisms of bromocriptine-induced hallucinations.
Topics: Bromocriptine; Hallucinations; Humans | 1980 |
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception | 1993 |
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM | 1993 |
Hallucinosis in idiopathic Parkinson's disease.
Topics: Aged; Bromocriptine; Cognition Disorders; Depressive Disorder; Dopamine Agonists; Female; Hallucinations; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Psychomotor Disorders; Retrospective Studies; Severity of Illness Index; Time Factors | 1997 |
Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation.
Topics: Accidental Falls; Adult; Akathisia, Drug-Induced; Amantadine; Brain Injuries; Bromocriptine; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Frontal Lobe; Hallucinations; Humans | 1999 |
Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
Topics: Aged; Bromocriptine; Confusion; Depression; Ergolines; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Neurocognitive Disorders; Parkinson Disease; Schizophrenia, Paranoid | 1978 |
Bromocriptine in parkinsonism. A long-term study.
Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System | 1978 |
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan | 1985 |
Low dose bromocriptine ameliorates hallucinations in a demented parkinsonian patient.
Topics: Aged; Bromocriptine; Dementia; Female; Hallucinations; Humans; Parkinson Disease | 1987 |
[Neuropsychic side effects of bromocriptine in Parkinson's disease].
Topics: Aged; Bromocriptine; Cognition Disorders; Delusions; Female; Hallucinations; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1987 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |